Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  02/23/2007
 
Trade Name:  Vyvanse Capsules
 
Generic Name or Proper Name (*):  lisdexamfetamine
 
Indications Studied:  Treatment of ADHD in children 6 to 12 years of age
 
Label Changes Summary:  Effectiveness established in two studies of patients 6-12 years of age Long-term effectiveness of more than 4 weeks has not been established Studies waived in children 0-5 years of age and deferred in children 13-17 years of age New active ingredient
 
Product Labeling:  Labeling  Opens a new window
 
PREA(P):  P
 
Sponsor:  New River
 
NNPS:  FALSE'
 
Therapeutic Category:  CNS Stimulant
 
-
-